Peter Devadason. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Antipsychotic Agents/administration & dosageAntipsychotic Agents/adverse effectsAustraliaBenzodiazepines/administration & dosageBenzodiazepines/adverse effectsCommitment of Mentally IllDelayed-Action PreparationsHealth Services MisuseHumansInjections, IntramuscularInservice Training/organization & administrationMonitoring, PhysiologicNew ZealandOlanzapinePatient Care TeamPatient Compliance/psychologyPsychiatric Department, HospitalPsychiatric Nursing/educationPsychotic Disorders/drug therapyPsychotic Disorders/nursingPsychotic Disorders/psychologyResuscitation/nursing
Substances: See more » Antipsychotic AgentsDelayed-Action PreparationsBenzodiazepinesOlanzapine
Year: 2010 PMID: 20482436 DOI: 10.3109/10398561003733912
Source DB: PubMed Journal: Australas Psychiatry ISSN: 1039-8562 Impact factor: 1.369